Loading clinical trials...
Loading clinical trials...
Effects of GLP-l Receptor Agonists on Cardiometabolic Alterations in HIV-associated Lipohypertrophy
Conditions
Interventions
Semaglutide Injectable Product
Placebo
Locations
2
United States
Case Western Reserve University
Cleveland, Ohio, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
May 16, 2019
Primary Completion Date
April 30, 2024
Completion Date
February 28, 2026
Last Updated
February 27, 2026
NCT07351045
NCT07543666
NCT07037459
NCT07508241
NCT07244458
NCT07395687
Lead Sponsor
Case Western Reserve University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions